NASDAQ:HUMA

Humacyte Stock Predictions

etoro logo Buy HUMA
*Your capital is at risk
$1.40
+0.0100 (+0.719%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HUMA Prediction Chart

HUMA Predictions History

Latest community submissions for HUMA.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 23, 2026 $1.09 -3.49% $1.14 X 95.66% 0
Feb 23, 2026 $1.11 -2.18% $1.14 X 96.96% 0
Aug 8, 2025 $2.39 -3.23% $2.48 X 96.38% 0
Aug 8, 2025 $2.42 -2.02% $2.48 X 97.59% 0
Aug 8, 2025 Bullish $2.48 V 1
May 30, 2025 $2.67 -3.51% $2.67 V 99.90% 6
May 30, 2025 $2.71 -2.19% $2.67 V 98.53% 2
May 30, 2025 Bullish $2.67 X 0
May 29, 2025 $2.53 -3.69% $2.77 X 91.44% 0
May 29, 2025 $2.57 -2.31% $2.77 X 92.76% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HUMA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HUMACYTE, INC.
Humacyte
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE